ROUNDTABLE Manufacturing Gene-Modified Cells: How Do We Get the Process Right?
Thursday, June 1, 2023 03:45 PM - 04:45 PM
Room 251
Manufacturing Tools & Technology
Roundtable
What are the innovative process development strategies that will improve the manufacturing space?
Moderator
Qasim Rafiq, PhD, MEng, Associate Professor, University College London, UK
Panelists
Josh Ludwig, BSc, Global Director, ScaleReady, USA
David Smith, MEng, PhD. VP Development, BioCentriq, USA
Amandine Breton, PhD, Director MSAT & AST, Orchard Therapeuticsm, UK
David Sourdive, PhD, Co-founder, Executive Vice President CMC and Manufacturing, Cellectis, France
Learning Objectives
- An understanding of the critical process development and manufacturing bottlenecks for gene-modified cells.
- Perspectives on the future of gene-delivery for ex-vivo gene-modified cellular therapies. Will it always be viral?
- Identifying the role and implementation of digital tools (e.g. Artificial Intelligence, Machine Learning, Digital Twins) and how they may support gene-modified cell therapy manufacture
